Global In Situ Hybridization (ISH) Market size was valued at US$ XX Mn in 2019 and the total revenue is expected to grow at 5.67% through 2020 to 2026, reaching nearly US$ XX Mn in the forecast period.
The global In Situ Hybridization (ISH) Market report is a comprehensive analysis of the industry, market, and key players. The report has covered the market by demand and supply-side by segments. The global In Situ Hybridization (ISH) Market report also provides trends by market segments, technology, and investment with a competitive landscape.
Global In Situ Hybridization (ISH) Market Overview:
In situ hybridization is a laboratory process that involves single-stranded DNA or RNA sequence called a probe to form complementary base pairs with DNA or RNA present in a tissue or chromosome taster. The probe has a chemical or radioactive label attached to it so that its binding can be detected to obtain the result of the test. This process is used to detect RNA and DNA in the animal or cell.
Global In Situ Hybridization (ISH) Market Dynamics:
The global in-situ hybridization was valued at USD 658 million in the year 2020 and is estimated to reach USD 845.3 million with a growing CAGR of 5.67% in the forecast period of 2020-2026.
Rising Genetic disorders like cancer, Down syndrome, hemophilia, thalassemia, turner syndrome, and sickle cell anemia are growing in this generation due to huge exposure to chemicals and hazards. And these abnormalities are further boosting the demand for in-situ hybridization laboratories. As per Global Cancer Incidence, Mortality and Prevalence (GLOBOCAN) in 2018 9.6 million deaths were caused by cancer and affected almost 43.9 million people around the world. And together with this 18.9 million new cases were reported. Cytogenetic assays are carried out ISH helps in combining IHC and DNA FISH to complete the situ toolset for the researcher to discover, develop and obtain new generation techniques for the disease’s cure. And this is further boosting the demand for in-situ hybridization techniques in the forecast period.
Additionally, this process involves the employment of skilled laborers for the handling of techniques and to carry out the process. And this factor can act as a challenge to the market player. Technological investment in the market and the innovation of new diagnoses and treatments are further creating opportunities for the market players to invest in the market. As high definition and latest technology diagnostic centers are installed to offer better services to the consumer in the healthcare sector.
Global In Situ Hybridization (ISH) Market Segment Analysis:
By Technique, the segment is bifurcated into FISH and CISH. The segment FISH stands for Fluorescent In-Situ Hybridization is dominating the technique segment of the global in-situ hybridization market. As this technique involves high resolution and accuracy, increased adoption is boosting the application of the Fluorescent In-Situ Hybridization (FISH) technique. Moreover, it offers benefits like high sensitivity and specificity in the recognition of DNA or RNA sequence of Strands. The direct application of metaphase chromosomes and interphase nuclei and imagining of hybridization signals in single cell-level. Moreover, this technique also helps in identifying the abnormality in the chromosomes. Additionally, this technique is used in Breast cancer treatment on the removed tissue of the breast by a biopsy to identify the multiples or copies of HER2 Gen. as Cancer is a cell proliferating disease.
Global In Situ Hybridization (ISH) Market
To know about the Research Methodology :- Request Free Sample Report
By Application, the segment is divided into Cancer Diagnosis, Neurosciences, Cytology, and Infectious Diseases. Cancer Diagnosis is a dominating sub-segment of the application segment in the global in-situ- hybridization market. As the rate of cancer is higher globally as compared to other diseases this has made the global government focus on health care diagnostics and improve the technique for early detection of cancer like In-situ hybridization, CISH, FISH, and others. Moreover, the techniques like probe-based technology, Silver ISH assay technology Chromogenic in-situ hybridization is further boosting the application of the global in-situ hybridization process in the forecast period of 2020-2026. Simultaneously, the rising use of DNA probe-based treatment for the identification of disease caused by bacteria and pathogen and surge in the occurrence of solid tumors, genetic disorders, leukemia (blood cancer), autism, and various other disorders caused by genetic disruption is further boosting the demand for in-situ hybridization market in the forecast period of 2020-2026.
Global In Situ Hybridization (ISH) Market
By end-user, the segment is divided into Molecular Diagnostic Laboratories and Academic and Research Institutes. Molecular Diagnostic Laboratories are dominating the end-user segment of the global in-situ hybridization market. In terms of infectious disease molecular diagnostic laboratories play an important role in serology. This method offers detection of the very lower amount of infection and infectious agent present in the body and allows early detection of contamination. Moreover, this process has revolutionized the treatment and the investigation of viral, microbial genomes, their genes, and the information of products they encode.
By product, the segment is categorized into Instruments and probes, and kits. Probes and kits are dominating the product segment of the global in-situ hybridization market. These products offer a quick detection of cancer and genetic disorders in the initial stage of treatment. Moreover, Kits and probes are anticipated to gain more attraction with growing CAGR in the forecast period of 2020-2026. Additionally, the growth is attributed to the wide range of kits and reagents used in the detection as well as research and diagnostic devices are further amplifying the market growth in a healthy direction.
Global In Situ Hybridization (ISH) Market Regional Insights:
North America is dominating the global in-situ hybridization market in the regional segment. The technological investment in the region and the demand for cancer treatment are boosting the market. Likewise, the increasing occurrence of genetic disease and disorder is further boosting the regional market and forcing the market to develop personalized testing kits and medicine and this factor is fueling the market growth of the In-situ hybridization process in the region. Furthermore, the cancer therapy treatment in North America is likely to grow with a CAGR of 8.2 in the forecast period of 2020-2026. And this growth is attributed to the strong research and development and rising cancer patient in the region together with government authorization and the presence of major market players like Abbott Laboratories, Biotech Corporation in North America.
Europe is second dominating in the in-situ hybridization market due to growing government initiatives and investment to develop and improve the healthcare system of the region. Europe has the latest and high-quality healthcare system across the world due to the presence of skilled professions and this factor is boosting the growth of In-situ hybridization in the European Market.
Global In Situ Hybridization (ISH) MarketThe objective of the report is to present a comprehensive analysis of the global In Situ Hybridization (ISH) Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.
PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.
The report also helps in understanding the global In Situ Hybridization (ISH) Market dynamics, structure by analyzing the market segments and project the global In Situ Hybridization (ISH) Market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the global In Situ Hybridization (ISH) Market make the report investor’s guide.
Global In Situ Hybridization (ISH) Market Scope: Inquire before buying
Global In Situ Hybridization (ISH) Market
Global In Situ Hybridization (ISH) Market, by Region
• North America
• Europe
• Asia Pacific
• The Middle East and Africa
• South America
Global In Situ Hybridization (ISH) Market Key Player
• Abbott Laboratories
• Thermo Fisher Scientific, Inc.
• Merck KgaA
• Advanced Cell Diagnostics, Inc.
• F. Hoffmann-La Roche
• Agilent Technologies
• Biogenex Laboratories, Inc.
• Exiqon A/S.
• Bio-Techne Corporation
• Qiagen N.V.
• Danaher Corporation
• Perkinelmer
• Enzo Biochem
• Bio-Rad Laboratories
• Abnova Corporation
• Biocare Medical
• Open
• Bio Sb
• Genemed Biotechnologies
• Abcam
• Creative Bioarray
• Biocat GmbH
• Zytovision
For More Information Visit @:
This Report Is Submitted By : Maximize Market Research Company
Customization of the report:
Maximize Market Research provides free personalized of reports as per your demand. This
report can be personalized to meet your requirements. Get in touch with us and our sales team
will guarantee provide you to get a report that suits your necessities.
About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging
opportunities & technologies as well as threats to the companies across the Healthcare,
Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages,
Aerospace and Defense and other manufacturing sectors.
